Clinical Trials Directory

Trials / Unknown

UnknownNCT02942342

Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo, MI

Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo County and Neighboring Areas in Michigan, Who Have Risk Factors of Coronary Artery Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Borgess Research Institute · Academic / Other
Sex
All
Age
35 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The primary goal of this study is to determine the prevalence of undiagnosed asymptomatic coronary artery disease (CAD) in Kalamazoo and its neighboring areas using Coronary Computed Tomography (CCTA) and Coronary Artery Calcium Score (CACS) to assess if asymptomatic CAD is widespread enough to warrant implementation of CCTA as a routine screening tool. Additionally, this study will use the CCTA results to evaluate several methods of assessing CAD risk in the asymptomatic population including Framingham Risk Score (FRS) and Reynold's Risk Score, Biomarkers (High sensitivity C-Reactive Protein, Fibrinogen, Vertical Auto Profile, oxidized Low Density Lipoprotein (LDL), Apolipoprotein A1 (ApoA1), Apolipoprotein B1 (ApoB1), Vitamin D, Homocysteine) as well as a large panel of genetic markers of atherosclerosis and dyslipidemia.

Conditions

Interventions

TypeNameDescription
PROCEDUREComputed Tomography (CT) ScanCT Scans will be used as a diagnostic tool for asymptomatic CAD.

Timeline

Start date
2016-03-01
Primary completion
2022-01-01
Completion
2022-03-01
First posted
2016-10-24
Last updated
2020-09-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02942342. Inclusion in this directory is not an endorsement.